Press Room

The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the Inherited Neuropathy Consortium (INC), is proud to announce the 2025 Inherited Neuropathy Fellowship. This one-year fellowship highlights how the CMTA-INC alliance drives progress by equipping ...

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a strategic alliance with the Inherited Neuropathy Consortium The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at ...

Exciting news from a CMTA-STAR-funded research project has been published by Jordan VerPlank, PhD, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the Uniformed Services University of the Health Sciences (USU). The ...

The Charcot-Marie-Tooth Association (CMTA), in collaboration with Actio Biosciences (Actio Bio), hosted a virtual patient focus group for individuals diagnosed with Charcot-Marie-Tooth disease Type 2C (CMT2C), also known as TRPV4 Neuropathy. Engaging volunteer experts from ...

With CMTA support of $302,071, an international team of researchers from the Inherited Neuropathies Consortium, led by Micheal Shy, MD, at the University of Iowa in Iowa City, IA, is studying the natural history of ...